| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8628769 | Cytokine | 2018 | 13 Pages |
Abstract
Finally, we discuss the potential of CCR5 as a drug target for diseases other than HIV, discussing the evidence linking CCR5 and its natural chemokine ligands with inflammatory diseases, particularly neuroinflammation, and certain cancers. These pathologies may provide new uses for the strategies for CCR5 blockade originally developed to combat HIV/AIDS.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Ilaria Scurci, Elsa Martins, Oliver Hartley,